Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr3 Inhibitors

Olr3 inhibitors represent a class of compounds characterized by their ability to selectively inhibit the activity of the Olr3 protein, a member of the olfactory receptor family. Olr3, or Olfactory Receptor 3, is part of the G-protein-coupled receptor (GPCR) superfamily, which is widely involved in the detection of chemical signals and the transduction of these signals into cellular responses. These receptors are primarily known for their role in the olfactory system, where they contribute to the detection of volatile compounds and the perception of smell. However, Olr3, like many other olfactory receptors, is also expressed in various tissues outside the olfactory epithelium, suggesting it may play broader roles in cellular signaling. The precise physiological functions of Olr3 are still being elucidated, but its inhibition could potentially modulate various cellular processes linked to this receptor.

The chemical structures of Olr3 inhibitors are diverse, reflecting the varied approaches in designing molecules that can effectively bind to and inhibit the Olr3 receptor. These inhibitors typically interact with the receptor's binding site, either competitively or non-competitively, thereby preventing the receptor from undergoing the conformational changes necessary for signal transduction. The structural complexity of Olr3 and its inhibitors often involves intricate stereochemistry and specific molecular interactions, such as hydrogen bonding, hydrophobic interactions, and van der Waals forces, which contribute to the selectivity and potency of the inhibition. The study of Olr3 inhibitors not only enhances the understanding of this specific receptor's role in cellular communication but also contributes to broader research on the function of GPCRs in various physiological contexts.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

Beta-adrenergic antagonist, might modulate GPCR activity, potentially affecting Olr3.

Carvedilol

72956-09-3sc-200157
sc-200157A
sc-200157B
sc-200157C
sc-200157D
100 mg
1 g
10 g
25 g
100 g
$124.00
$240.00
$530.00
$999.00
$1530.00
2
(1)

Beta-adrenergic antagonist with alpha-1 blocking activity, could influence Olr3 signaling.

Yohimbine hydrochloride

65-19-0sc-204412
sc-204412A
sc-204412B
1 g
5 g
25 g
$51.00
$171.00
$530.00
2
(1)

Alpha-2 adrenergic receptor antagonist, may affect GPCR signaling pathways related to Olr3.

Labetalol

36894-69-6sc-484723
50 mg
$180.00
(0)

Combined alpha and beta blocker, could indirectly affect GPCR pathways, including Olr3.

Pindolol

13523-86-9sc-204847
sc-204847A
100 mg
1 g
$194.00
$760.00
(1)

Beta-adrenergic antagonist, may influence GPCR-mediated signaling pathways related to Olr3.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

Beta-adrenergic agonist, could indirectly affect Olr3 through GPCR modulation.

Atropine

51-55-8sc-252392
5 g
$204.00
2
(1)

Muscarinic acetylcholine receptor antagonist, may influence GPCR signaling pathways including Olr3.

Salmeterol

89365-50-4sc-224277
sc-224277A
10 mg
50 mg
$186.00
$562.00
1
(1)

Beta-2 adrenergic agonist, potentially affecting GPCR pathways related to Olr3.

Alprenolol

13655-52-2sc-507469
50 mg
$130.00
(0)

Beta blocker, could indirectly influence GPCR signaling pathways including Olr3.